| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.08 | 0.1 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | -0.065 | 0.1 |
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.1 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.1 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.1 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.065 | 0.1 |
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | -0.064 | 0.1 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.065 | 0.1 |